Location History:
- Foster City, CA (US) (2014)
- Bromma, SE (2012 - 2021)
Company Filing History:
Years Active: 2012-2021
Title: Innovations of Markus Jerling
Introduction
Markus Jerling is a notable inventor based in Bromma, Sweden. He has made significant contributions to the field of medicine, particularly in the treatment of essential tremor and diabetes. With a total of three patents to his name, Jerling's work reflects a commitment to advancing healthcare solutions.
Latest Patents
One of Jerling's latest patents is for the steroid compound 3-beta-hydroxy-5-alpha-pregnan-20-one, which is designed for use in the treatment of essential tremor. This invention not only provides a new therapeutic option but also includes methods and pharmaceutical compositions aimed at effectively managing this condition. Another significant patent involves methods for treating diabetes. This innovation focuses on lowering plasma levels of HbA1c, glucose, total cholesterol, and triglycerides while increasing HDL cholesterol levels. It also aims to delay the onset of diabetic retinopathy in various mammals, all while minimizing undesirable side effects.
Career Highlights
Throughout his career, Jerling has worked with prominent companies such as Gilead Sciences, Inc. and Asarina Pharma AB. His experience in these organizations has undoubtedly contributed to his expertise and innovative capabilities in the pharmaceutical industry.
Collaborations
Jerling has collaborated with notable professionals in his field, including Andrew A. Wolff and Torbjörn Bäckström. These partnerships have likely enhanced his research and development efforts, leading to impactful inventions.
Conclusion
Markus Jerling's contributions to medical innovation, particularly in the treatment of essential tremor and diabetes, highlight his role as a significant inventor. His patents reflect a dedication to improving patient outcomes and advancing medical science.